MSK Bergen — Montvale, New Jersey

MSK Bergen is a clinical research site located in Montvale, New Jersey, United States 07645.

Crixeo Clinical Trials Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

MSK Bergen has participated in 12 clinical trials with 8 currently active.

Therapeutic areas: Multiple Myeloma, Advanced Malignancies, NSCLC.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Bergen?

MSK Bergen has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Bergen conducted?

MSK Bergen has 12 clinical trials on record, with 8 currently active. Their work covers Multiple Myeloma, Advanced Malignancies, NSCLC.

Is MSK Bergen accredited by Crixeo Clinical Trials?

MSK Bergen has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MSK Bergen?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.